I believe Herceptin is off patent.
If Roche and IMU trial Herr-Vaxx + Herceptin, can this combination be separately patented, and if so would this preclude the use of Herr-Vaxx with a Herceptin bio-similar?
If so, that would be a big incentive for Roche to partner with IMU!
Media Thread, page-1010
-
- There are more pages in this discussion • 13,889 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $407.8M | |||
| Open | High | Low | Value | Volume |
| 5.5¢ | 5.6¢ | 5.5¢ | $307.3K | 5.574M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 21 | 1006452 | 5.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.6¢ | 612360 | 18 |
View Market Depth
| Last trade - 11.15am 25/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |